Oxford Researchers Develop Tool to Assess Statin Muscle Disorder Risk

Researchers at the University of Oxford have created a new calculator designed to help both patients and physicians evaluate an individual's specific risk of developing severe muscle disorders from statin therapy. Published in The Lancet Digital Health, the study suggests that over 98% of eligible statin users face a low 10-year risk, potentially easing widespread concerns about these side effects.